Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Primary pigmented nodular adrenocortical disease and Cushing s syndrome Horvath A; Stratakis CArq Bras Endocrinol Metabol 2007[Nov]; 51 (8): 1238-44Primary pigmented nodular adrenocortical disease (PPNAD) is a form of bilateral adrenocortical hyperplasia that is often associated with corticotrophin (ACTH)-independent Cushing's syndrome (CS) and is characterized by small to normal-sized adrenal glands containing multiple small cortical pigmented nodules (1,2). PPNAD may occur in an isolated form or associated with a multiple neoplasia syndrome, the complex of spotty skin pigmentation, myxomas, and endocrine overactivity, or Carney complex, in which Cushing's syndrome is the most common endocrine manifestation (3). Molecular studies have led to the identification of several genes, defects in which may predispose PPNAD formation; all of these molecules play important role for the cAMP signaling pathway. This review intends to present the most recent knowledge of the pathology and molecular genetics of the benign bilateral adrenocortical lesions, as well as to discuss the modern tools for diagnostics and treatment of this condition.|3',5'-Cyclic-GMP Phosphodiesterases[MESH]|Adrenal Cortex Diseases/complications/diagnosis/*genetics[MESH]|Adrenal Glands/*pathology[MESH]|Cushing Syndrome/*etiology[MESH]|Cyclic AMP-Dependent Protein Kinase RIalpha Subunit/genetics[MESH]|Cyclic AMP/physiology[MESH]|Humans[MESH]|Hyperplasia/complications/pathology[MESH]|Multiple Endocrine Neoplasia/complications[MESH]|Mutation/genetics[MESH]|Phosphoric Diester Hydrolases/genetics[MESH]|Pigmentation Disorders/*genetics[MESH] |